Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Temperature intolerance, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: extreme heat; anxious; Covid arm; allergic reaction/bumpiness; warmth; itching; swelling; some pain in my injection site; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of TEMPERATURE INTOLERANCE (extreme heat), ANXIETY (anxious), HYPERSENSITIVITY (Covid arm), ALLERGY TO VACCINE (allergic reaction/bumpiness) and FEELING HOT (warmth) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history information was reported.     On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced FATIGUE (fatigue). On 04-Feb-2021, the patient experienced TEMPERATURE INTOLERANCE (extreme heat), ANXIETY (anxious), HYPERSENSITIVITY (Covid arm), ALLERGY TO VACCINE (allergic reaction/bumpiness), FEELING HOT (warmth), VACCINATION SITE PRURITUS (itching), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE PAIN (some pain in my injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 27-Jan-2021, FATIGUE (fatigue) had resolved. On 08-Feb-2021, ANXIETY (anxious), VACCINATION SITE PRURITUS (itching) and VACCINATION SITE PAIN (some pain in my injection site) had resolved. At the time of the report, TEMPERATURE INTOLERANCE (extreme heat), ALLERGY TO VACCINE (allergic reaction/bumpiness), FEELING HOT (warmth) and VACCINATION SITE SWELLING (swelling) was resolving and HYPERSENSITIVITY (Covid arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Feb-2021 and was forwarded to the company on 17-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TEMPERATURE INTOLERANCE (extreme heat), ANXIETY (anxious), HYPERSENSITIVITY (Covid arm), ALLERGY TO VACCINE (allergic reaction/bumpiness) and FEELING HOT (warmth) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history information was reported.     On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced FATIGUE (fatigue). On 04-Feb-2021, the patient experienced TEMPERATURE INTOLERANCE (extreme heat), ANXIETY (anxious), HYPERSENSITIVITY (Covid arm), ALLERGY TO VACCINE (allergic reaction/bumpiness), FEELING HOT (warmth), VACCINATION SITE PRURITUS (itching), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE PAIN (some pain in my injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 27-Jan-2021, FATIGUE (fatigue) had resolved. On 08-Feb-2021, ANXIETY (anxious), VACCINATION SITE PRURITUS (itching) and VACCINATION SITE PAIN (some pain in my injection site) had resolved. At the time of the report, TEMPERATURE INTOLERANCE (extreme heat), ALLERGY TO VACCINE (allergic reaction/bumpiness), FEELING HOT (warmth) and VACCINATION SITE SWELLING (swelling) was resolving and HYPERSENSITIVITY (Covid arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter.